Vitamin H: Slow increase in terminal demand and overcapacity
Vitamin H is one of the B vitamins, also known as biotin, vitamin B7, coenzyme R (Coenzyme R), etc. It is an essential substance for the synthesis of vitamin C and an indispensable substance for metabolism. It is a nutrient necessary to maintain the human body's natural growth, development and normal human function and health. Vitamin H is currently mainly used in food and beverage, medicine, feed additives and other fields, of which feed additives account for a relatively high proportion of about 75%, followed by the pharmaceutical field accounting for about 18%, and the food and beverage field accounting for the lowest proportion at 7% about.
In recent years, under the background of stricter supervision on environmental protection and production safety, China’s vitamin production technology has been continuously improved, increasing production efficiency, expanding production, and reducing production costs. With a higher cost performance, it has become popular in overseas markets and exported. Higher.
The livestock and poultry breeding industry has developed for a long time, and the market growth rate has slowed down. Affected by factors such as African swine fever and the epidemic, the market demand for feed additives has increased. Therefore, the global vitamin H market demand is growing at a rate of about 5%. About 254 tons per year, of which more than 80% of the demand comes from overseas markets.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
FDA Tracks Industry Dye Removal
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
India Prepares New Seed and Pesticide Laws
-
Syngenta Caught in Trade Crossfire
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
Recommend Reading
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
Thymol Gel Wins EPA Approval for Beekeepers
-
Negative Factors Weighing Down, Palm Oil Prices Weak and Declining
-
Bearish Pressure Continues to Drive Down Hydrogen Peroxide Prices in China
-
Supply Increase Leads to a Rebound and Subsequent Decline in the Acrylonitrile Market in China
-
Supply-Demand Dynamics Dominate Market Trends; Formic Acid Prices Stabilize and Remain Flat
-
Cost Easing and Weakening Year-End Demand Leave Acrylic Market Stuck in a Standoff